These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28426652)

  • 1. Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).
    Melagraki G; Ntougkos E; Rinotas V; Papaneophytou C; Leonis G; Mavromoustakos T; Kontopidis G; Douni E; Afantitis A; Kollias G
    PLoS Comput Biol; 2017 Apr; 13(4):e1005372. PubMed ID: 28426652
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Melagraki G; Ntougkos E; Papadopoulou D; Rinotas V; Leonis G; Douni E; Afantitis A; Kollias G
    Front Pharmacol; 2018; 9():800. PubMed ID: 30090063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index.
    Rinotas V; Papakyriakou A; Violitzi F; Papaneophytou C; Ouzouni MD; Alexiou P; Strongilos A; Couladouros E; Kontopidis G; Eliopoulos E; Douni E
    J Med Chem; 2020 Oct; 63(20):12043-12059. PubMed ID: 32955874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
    Douni E; Rinotas V; Makrinou E; Zwerina J; Penninger JM; Eliopoulos E; Schett G; Kollias G
    Hum Mol Genet; 2012 Feb; 21(4):784-98. PubMed ID: 22068587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation.
    Halim SA; Sikandari AG; Khan A; Wadood A; Fatmi MQ; Csuk R; Al-Harrasi A
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyrin Derivatives Inhibit the Interaction between Receptor Activator of NF-κB and Its Ligand.
    Chypre M; Madel MB; Chaloin O; Blin-Wakkach C; Morice C; Mueller CG
    ChemMedChem; 2017 Oct; 12(20):1697-1702. PubMed ID: 28885764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes.
    Papadopoulou D; Drakopoulos A; Lagarias P; Melagraki G; Kollias G; Afantitis A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches.
    Saddala MS; Huang H
    J Transl Med; 2019 Jul; 17(1):215. PubMed ID: 31266509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
    Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
    Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status and Future Prospects of Small-molecule Protein-protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).
    Melagraki G; Leonis G; Ntougkos E; Rinotas V; Papaneophytou C; Mavromoustakos T; Kontopidis G; Douni E; Kollias G; Afantitis A
    Curr Top Med Chem; 2018; 18(8):661-673. PubMed ID: 29875003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-alpha stimulated Jurkat cells.
    Wu L; Lin JH; Bao K; Li PF; Zhang WG
    Int Immunopharmacol; 2009 Aug; 9(9):1105-9. PubMed ID: 19500694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha expression is transcriptionally regulated by RANK ligand.
    Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z
    J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
    Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
    Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
    J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay.
    Chen S; Feng Z; Wang Y; Ma S; Hu Z; Yang P; Chai Y; Xie X
    J Chem Inf Model; 2017 May; 57(5):1101-1111. PubMed ID: 28422491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-α enhances RANKL expression in gingival epithelial cells via protein kinase A signaling.
    Fujihara R; Usui M; Yamamoto G; Nishii K; Tsukamoto Y; Okamatsu Y; Sato T; Asou Y; Nakashima K; Yamamoto M
    J Periodontal Res; 2014 Aug; 49(4):508-17. PubMed ID: 24102429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL.
    Suda K; Woo JT; Takami M; Sexton PM; Nagai K
    J Cell Physiol; 2002 Jan; 190(1):101-8. PubMed ID: 11807816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
    Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
    Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.